Clinical Trials Browser

Phase 2 × INDUSTRY × lanreotide × Clear all

NCT00326469 2020-11-05

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

Phase 2 Completed

Neuroendocrine Tumors

NCT02698410 2020-10-01

ATLANT

Phase 2 Completed

40 enrolled 17 charts

Neuroendocrine Tumors